TGFB1 and pulmonary fibrosis: The combination of astragaloside IV and ferulic acid reduced oxidative stress, collagen synthesis, and inhibited the TGF-β1/Smad3 signaling pathway through miR-29b regulation, thereby reducing the damage from pulmonary fibrosis.